Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
June 1, 1995
Oral etoposide as second-line chemotherapy for colorectal cancer: a GISCAD study. Gruppo Italiano Studio Carcinomi Apparato Digerente
A Zaniboni, R Labianca, G Pancera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Efficacy of intraportal infusion for colon cancer: a fair assessment?
S Marsoni, V Torri, A Taiana, et al.
British Journal of Cancer
|
August 14, 1998
Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, R Labianca, F Graziano, et al.
Annali Italiani Di Chirurgia
|
November 1, 1996
[Locoregional chemotherapy of liver metastasis from colorectal carcinoma]
G Zamparelli, G Pancera, M A Pessi, et al.
Cancer
|
November 15, 1995
Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report
A Zaniboni, S Barni, R Labianca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, G Gasparini, V Catalano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract Cancer
R Labianca, G Giaccon, S Barni, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer)
R Labianca, G Pancera, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1991
Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer)
R Labianca, G Pancera, E Aitini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma
R Rosso, T Mazzei, A Sobrero, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Journal of Chemotherapy (Florence, Italy)
|
June 1, 1995
Oral etoposide as second-line chemotherapy for colorectal cancer: a GISCAD study. Gruppo Italiano Studio Carcinomi Apparato Digerente
A Zaniboni, R Labianca, G Pancera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Efficacy of intraportal infusion for colon cancer: a fair assessment?
S Marsoni, V Torri, A Taiana, et al.
British Journal of Cancer
|
August 14, 1998
Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, R Labianca, F Graziano, et al.
Annali Italiani Di Chirurgia
|
November 1, 1996
[Locoregional chemotherapy of liver metastasis from colorectal carcinoma]
G Zamparelli, G Pancera, M A Pessi, et al.
Cancer
|
November 15, 1995
Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) report
A Zaniboni, S Barni, R Labianca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, G Gasparini, V Catalano, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract Cancer
R Labianca, G Giaccon, S Barni, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer)
R Labianca, G Pancera, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1991
Folinic acid + 5-fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of 'GISCAD' (Italian Group for the Study of Digestive Tract Cancer)
R Labianca, G Pancera, E Aitini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Phase II trial of 5-fluorouracil and the natural l isomer of folinic acid in the treatment of advanced colorectal carcinoma
R Rosso, T Mazzei, A Sobrero, et al.
Page
of 3